Myelodysplastic Syndromes (MDS)

Diagnosis and management of MDS.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
HaematologyOncology

Clinical Guidelines

CKS: Haematological cancers - recognition and referral
National
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet (Malcovati et al., 2013)
National
ESMO Clinical Practice Guideline: Myelodysplastic Syndromes
National
Guidelines for the management of adult myelodysplastic syndromes (British Society for Haematology, 2021)
National
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2020)
National
NICE Guidance TA322: Lenalidomide for treating myelodysplastic syndromes
National
Consensus proposal for revised International Working Group 2023 response criteria for myelodysplastic syndromes
Local
Consensus statement on iron overload in myelodysplastic syndromes
Local
ESMO Clinical Practice Guideline: Myelodysplastic Syndromes
Local
Myelodysplastic Syndromes Treatment (PDQ®) - NCI
Local
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Local
NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic Syndromes
Local